Myasthenic syndromes in Turkish kinships due to mutations in the acetylcholine receptor

Annals of Neurology

Volumn 44, Issue 2, 1998, Pages 234-241

  Ohno, Kinji ^a   Anlar, Banu ^b   Özdirim, Emire ^b   Brengman, Joan M ^a   DeBleecker, Jan L ^c   Engel, Andrew G ^a  

^a MAYO CLINIC   (United States)

^b HACETTEPE UNIVERSITY   (Turkey)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR;

ACETYLCHOLINE RELEASE; ARTICLE; GENE MUTATION; HUMAN; HUMAN CELL; MYASTHENIA; NEUROMUSCULAR TRANSMISSION; PRIORITY JOURNAL; TURKEY (REPUBLIC);

BASE SEQUENCE; DNA; FEMALE; FRAMESHIFT MUTATION; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; MYASTHENIA GRAVIS; PEDIGREE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CHOLINERGIC; SYNDROME; TURKEY;

EID: 0031829201     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440214     Document Type: Article

References (43)

1. Engel AG, Lambert EH, Gomez MR. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release. Ann Neurol 1977;1:315-330
2. Hutchinson DO, Walls TJ, Nakano S, et al. Congenital endplate acetylcholinesterase deficiency. Brain 1993;116:633-653
3. Walls TJ, Engel AG, Nagel AS, et al. Congenital myasthenic syndrome associated with paucity of synaptic vesicles and reduced quantal release. Ann NY Acad Sci 1993;681:461-468
4. Mora M, Lambert EH, Engel AG. Synaptic vesicle abnormality in familial infantile myasthenia. Neurology 1987;37:206-214
5. Engel AG. Myasthenic syndromes. In: Engel AG, Franzini-Armstrong C, eds. Myology: basic and clinical. 2nd ed. New York: McGraw-Hill, 1994;1798-1835
6. Sine SM, Ohno K, Bouzat C, et al. Mutation of the acetylcholine receptor α subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron 1995;15: 229-239
7. Wang H-L, Auerbach A, Bren N, et al. Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J Gen Physiol 1997;109:757-766
8. Croxen R, Newland C, Beeson D, et al. Mutations in different functional domains of the human muscle acetylcholine receptor α subunit in patients with the slow-channel congenital myasthenic syndrome. Hum Mol Genet 1997;6:767-773
9. Milone M, Wang H-L, Ohno K, et al. Slow-channel syndrome caused by enhanced activation, desensitization, and agonist binding affinity due to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J Neurosci 1997;17:5651-5665
10. Engel AG, Ohno K, Milone M, et al. New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet 1996;5:1217-1227
11. Gomez CM, Maselli R, Gammack J, et al. A beta-subunit mutation in the acetylcholine receptor gate causes severe slow-channel syndrome. Ann Neurol 1996;39:712-723
12. Ohno K, Hutchinson DO, Milone M, et al. Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the ε subunit. Proc Natl Acad Sci USA 1995;92:758-762
13. Ohno K, Wang H-L, Milone M, et al. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor ε subunit. Neuron 1996; 17:157-170
14. Engel AG, Ohno K, Bouzat C, et al. End-plate acetylcholine receptor deficiency due to nonsense mutations in the ε subunit. Ann Neurol 1996;40:810-817
15. Ohno K, Quiram P, Milone M, et al. Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor ε subunit gene: identification and functional characrerization of six new mutations. Hum Mol Genet 1997;6:753-766
16. Sambrook J, Fritsch EF, Maniaris T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989
17. Schoepfer R, Luther M, Lindstrom J. The human medulloblastoma cell line TE671 expresses a muscle-like acetylcholine receptor. Cloning of the alpha-subunit cDNA. FEBS Lett 1988; 226:235-240
18. Luther MA, Schoepfer R, Whiting P, et al. A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671. J Neurosci 1989;9:1082-1096
19. Lee BS, Gunn RB, Kopito RR. Functional differences among nonerythroid anion exchangers expressed in a α transfected human cell line. J Biol Chem 1991;266:11448-11454
20. Maquar LE. Defects in RNA splicing and the consequences of shortened translational reading frames. Am J Hum Genet 1996; 59:279-286
21. Nakai K, Sakamoto H. Construction of a novel data base containing aberrant splicing mutations of mammalian genes. Gene 1994;141:171-177
22. Papworth C, Bauer JC, Braman J, Wright DA. Site-directed mutagenesis in one day with >80% efficiency. Strategies 1996; 9:3-4
23. Sarkar G, Sommer SS. The "megaprimer" method of site-directed mutagenesis. Biotechniques 1990;8:404-407
24. Wang Z-Z, Hardy SF, Hall ZW. Assembly of the nicotinic acetylcholine receptor. The first transmembrane domains of truncated alpha and delta subunits are required for heterodimer formation in vivo. J Biol Chem 1996;271:27575-27584
25. Sine SM, Taylor P. Functional consequences of agonist mediated state transitions in the cholinergic receptor. Studies in cultured muscle cells. J Biol Chem 1979;254:3315-3325
26. Milone M, Wang H-L, Ohno K, et al. Mode switching kinetics produced by a naturally occuring mutation in the cytoplasmic loop of the human acetylcholine receptor epsilon subunit. Neuron 1998;20:575-588
27. Sine SM, Claudio T. Gamma and delta subunits regulate the affinity and the cooperativity of ligand binding to the acetylcholine receptor. J Biol Chem 1991;266:19369-19377
28. Blount P, Smith MM, Merlie JP. Assembly intermediates of the mouse nicotinic acetylcholine receptor in stably transfected fibroblasts. J Cell Biol 1990;111:2601-2611
29. Green W, Millar N. Ion-channel assembly. Trends Neurosci 1995;18:280-286
30. Sachs AB. Messenger RNA degradation in eukaryotes. Cell 1993;74:413-421
31. Beelman CA, Parker R. Degradation of mRNA in eukaryotes. Cell 1995;81:179-183
32. Maquat LE. When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. RNA 1995;1: 453-465
33. Aoufouchi S, Yélamos J, Milstein C. Nonsense mutations inhibit RNA splicing in a cell-free system: recognition of mutant codon is independent of protein synthesis. Cell 1996;85:415-422
34. Losson R, Lacroute F. Interference of nonsense mutations with eukaryotic messenger RNA stability. Proc Natl Acad Sci USA 1979;76:5134-5137
35. Perlick HA, Medgalchi SM, Spencer FA, et al. Mammalian orthologues of a yeast regulator of nonsense transcript stability. Proc Natl Acad Sci USA 1996;93:10928-10932
36. Shapiro MB, Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 1987;15:7155-7174
37. Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992;90: 41-54
38. Hesselmans LFGM, Jennekens FGI, Vand Den Oord CJM, et al. Development of innervation of skeletal muscle fibers in man: relation to acetylcholine receptors. Anat Rec 1993;236:553-562
39. Witzemann V, Schwartz H, Koenen M, et al. Acetylcholine receptor epsilon subunit deletion causes muscle weakness and atrophy in juvenile and adult mice. Proc Natl Acad Sci USA 1996;93:13286-13291
40. Missias AC, Mudd J, Cunningham JM, et al. Deficient development and maintenance of postsynaptic specializations in mutant mice lacking an "adult" acetylcholine receptor subunit. Development 1997;124:5075-5086
41. Krawczak M, Cooper DN. Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet 1991;86:425-441
42. Liu Y, Brehm P. Expression of subunit-omitted mouse nicotinic acetylcholine receptors in Xenopus laevis oocytes. J Physiol (Lond) 1993;470:349-363
43. Ad Hoc Committee on Mutation Nomenclature. Update on nomenclature for human gene mutations. Hum Mutat 1996;8: 197-202